Clinical Trial Update: Aripiprazole for the Treatment of Refractory Anxiety [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating aripiprazole for treatment-refractory anxiety, including generalized anxiety disorder and panic disorder; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Panic Disorder

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Generalized Anxiety Disorder, Panic Disorder | Phase 4 | Status: COMPLETED